What is the recommended dose of salbutamol (albuterol) syrup for children and adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Salbutamol Syrup Recommended Dose

For children weighing ≥15 kg and adults, the recommended dose is 2.5 mg (one vial of 0.083% solution) administered three to four times daily by nebulization, or 4 mg of oral syrup four times daily for children 6-14 years of age. 1, 2

Dosing by Age and Weight

Children Under 2 Years

  • Safety established but specific syrup dosing not well-defined in FDA labeling 1
  • Historical studies suggest 1-2 mg every 8 hours is safe for children 2-6 years 3
  • Inhaled formulations (MDI preferred over nebulizer) are safer than oral in this age group 4

Children 2-6 Years

  • Oral syrup: 1-2 mg every 8 hours (three times daily) 5, 3
  • This provides effective symptom control with minimal side effects
  • The 2 mg dose may cause more tremors and personality changes 5

Children 6-14 Years

  • Oral syrup: 4 mg (2 mg/5 mL) four times daily is the preferred dose 2
  • The syrup formulation is superior to tablets, with peak effect at 4 hours lasting 6 hours 2
  • The 6 mg dose causes more side effects without significantly better efficacy 2

Children Weighing <15 kg (Nebulized)

  • Use 0.5% concentration solution instead of 0.083% to allow for doses less than 2.5 mg 1
  • Dose not specifically established in FDA labeling for this weight group

Children Weighing ≥15 kg and Adults (Nebulized)

  • 2.5 mg (entire 3 mL vial of 0.083% solution) three to four times daily 1
  • Delivered over 5-15 minutes via nebulization
  • More frequent administration or higher doses are not recommended for routine use 1

Acute Exacerbations (Per Guidelines)

For acute asthma exacerbations, dosing differs significantly from maintenance therapy:

Children (Nebulized)

  • 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for 3 doses 6
  • Then 0.15-0.3 mg/kg every 1-4 hours as needed
  • For continuous nebulization in critical exacerbations: starting at 10 mg/hour is as effective as 15 mg/hour with shorter treatment duration 7

Adults (Nebulized)

  • 2.5-5 mg every 20 minutes for 3 doses 6
  • Then 2.5-10 mg every 1-4 hours as needed

MDI Dosing (All Ages)

  • 4-8 puffs (90 mcg/puff) every 20 minutes for 3 doses 6
  • Then every 1-4 hours as needed
  • MDI with valved holding chamber is as effective as nebulized therapy in mild-to-moderate exacerbations 6

Important Clinical Considerations

Common pitfalls to avoid:

  • Do not use nebulized salbutamol as first-line in children <2 years—MDI formulation is safer with lower adverse reaction rates 4
  • Back-to-back dosing (multiple consecutive doses) provides no additional benefit over single dosing in children who respond initially (FEV1 ≥12% improvement) 8
  • Syrup formulation has longer duration of action than tablets in children, making it the preferred oral formulation 2

Expected side effects:

  • Tremors are most common (75-85% of patients) 9
  • Palpitations occur in approximately 25% with salbutamol 9
  • Heart rate increases are expected and statistically significant but rarely clinically concerning 9
  • Severe adverse effects requiring treatment discontinuation are extremely rare 4

When to escalate therapy:

  • If a previously effective dosage regimen fails to provide usual relief, this signals seriously worsening asthma requiring immediate reassessment 1
  • Consider adding ipratropium for severe exacerbations 6
  • Oral corticosteroids (1-2 mg/kg/day, maximum 60 mg/day for 3-10 days in children; 40-60 mg/day for 5-10 days in adults) should be added for moderate to severe exacerbations 6, 10

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.